Assuero Giorgetti

Assuero Giorgetti

Auto-generated profile, based on publicly available information

Assuero Giorgetti

Fondazione Toscana Gabriele Monasterio

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
APAngela Pucci
Angela Pucci
AAAlberto Aimo
Alberto Aimo
VMVeronica Musetti
Veronica Musetti
Andrea BarisonAndrea Barison
Andrea Barison
GVGiuseppe Vergaro
Giuseppe Vergaro
MEMichele Emdin
Michele Emdin
Background: The relative contribution of amyloid and fibrosis to extracellular volume expansion in cardiac amyloidosis (CA) has never been defined. Methods and Results: We included all patients diagnosed with amyloid light‐chain (AL) or transthyretin cardiac amyloidosis at a tertiary referral center between 2014 to 2020 and undergoing a left ventricular endomyocardial biopsy. Patients (n=37) were more often men (92%), with a median age of 72 years (interquartile range, 68–81). Lambda‐positive AL was found in 14 of 19 AL cases (38%) and kappa‐positive AL in 5 of 19 (14%), while transthyretin was detected in the other 18 cases (48%). Amyloid deposits accounted for 15% of tissue sample area (10%–30%), without significant differences between AL and transthyretin amyloidosis. All patients displayed myocardial fibrosis, with a median extent of 15% of tissue samples (10%–23%; range, 5%–60%), in the absence of spatial overlap with amyloid deposits. Interstitial fibrosis was often associated with mild and focal subendocardial fibrosis. The extent of fibrosis or the combination of amyloidosis and fibrosis did not differ significantly between transthyretin amyloidosis and AL subgroups. In 20 patients with myocardial T1 mapping at cardiac magnetic resonance, the combined amyloid and fibrosis extent displayed a modest correlation with extracellular volume ( r =0.661, P =0.001). The combined amyloid and fibrosis extent correlated with high‐sensitivity troponin T ( P =0.035) and N‐terminal pro‐B‐type natriuretic peptide ( P =0.002) serum levels. Conclusions: Extracellular spaces in cardiac amyloidosis are enlarged to a similar extent by amyloid deposits and fibrotic tissue. Their combination can better explain the increased extracellular volume at cardiac magnetic resonance and circulating biomarkers than amyloid extent alone.

25 July 2013 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
AGAssuero Giorgetti
Assuero Giorgetti
PMPier Giorgio Masci
Pier Giorgio Masci
GMGavino Marras
Gavino Marras
YRYasmine K. Rustamova
Yasmine K. Rustamova
AGAlessia Gimelli
Alessia Gimelli
PMPaolo Marzullo
Paolo Marzullo

16 February 2021 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
Maria Filomena SantarelliMaria Filomena Santarelli
Maria Filomena Santarelli
DGDario Genovesi
Dario Genovesi
Vincenzo PositanoVincenzo Positano
Vincenzo Positano
MSMichele Scipioni
Michele Scipioni
GVGiuseppe Vergaro
Giuseppe Vergaro
PMPaolo Marzullo
Paolo Marzullo

28 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
VMVeronica Musetti
Veronica Musetti
FGFrancesco Greco
Francesco Greco
VCVincenzo Castiglione
Vincenzo Castiglione
AAAlberto Aimo
Alberto Aimo
CPCataldo Palmieri
Cataldo Palmieri
APAngela Pucci
Angela Pucci
Cardiac amyloidosis (CA) has long been considered a rare disease, but recent advancements in diagnostic tools have led to a reconsideration of the epidemiology of CA. Amyloid light-chain (AL) and transthyretin (ATTR) amyloidoses are the most common forms of cardiac amyloidosis. Due to the distinct treatments and the different prognoses, amyloid typing is crucial. Although a non-biopsy diagnosis can be obtained in ATTR amyloidosis when certain diagnostic criteria are fulfilled, tissue characterization still represents the gold standard for the diagnosis and typing of CA, particularly in AL amyloidosis. The present review focuses on the status of tissue characterization in cardiac amyloidosis, from histochemistry to immunohistochemistry and mass spectrometry, as well as on its future directions.

1 July 1997 in JACC
Verified
Journal Article
Closed access
MTMarco Antonio Rodrigues Torres
Marco Antonio Rodrigues Torres
EPEugenio Picano
Eugenio Picano
GPGuido Parodi
Guido Parodi
RSRosa Sicari
Rosa Sicari
FVFabrizio Veglia
Fabrizio Veglia
OPOberdan Parodi
Oberdan Parodi

3 February 2017 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
AGAssuero Giorgetti
Assuero Giorgetti
GMGavino Marras
Gavino Marras
DGDario Genovesi
Dario Genovesi
EFElena Filidei
Elena Filidei
ABAntonio Bottoni
Antonio Bottoni
PMPaolo Marzullo
Paolo Marzullo